Reduction of hyperphosphatemia is related with the reduction of C-reactive protein in dialysis patients. Study in sevelamer-resistant dialysis patients treated with chitosan chewing gum as salivary phosphate binder

Renal Failure

Volumn 33, Issue 1, 2011, Pages 11-14

  Calò, Lorenzo A ^a   Savica, Vincenzo ^b   Piccoli, Antonio ^a   Fusaro, Maria ^a   D'Angelo, Angela ^a   Davis, Paul A ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiovascular risk; Dialysis; HsCRP; Hyperphosphatemia; Inflammation

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; CHITOSAN; PHOSPHATE; SEVELAMER;

ADULT; AGED; ARTICLE; CHEWING GUM; CLINICAL ARTICLE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; HYPERPHOSPHATEMIA; MALE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; SALIVA;

ADULT; AGED; C-REACTIVE PROTEIN; CHELATING AGENTS; CHEWING GUM; CHITOSAN; FEMALE; HUMANS; HYPERPHOSPHATEMIA; MALE; MIDDLE AGED; PHOSPHATES; POLYAMINES; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 78651304822     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.528116     Document Type: Article

References (11)

1. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO4, Ca × PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol. 2001; 12:2131-2138.
2. Ross, R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-126.
3. Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2000; 35:469-476.
4. Di Marco GS, Hausberg M, Hillebrand U, et al. Increased inorganic phosphate induces human endothe-lial cell apoptosis in vitro. Am J Physiol Renal Physiol. 2008;294:F1381-F1387.
5. Yamada K, Fujimoto S, Tokura T, et al. Effect of sevelamer on dyslipidemia and chronic inflammation in maintenance hemodialysis patients. Ren Fail. 2005;27:361-365.
6. Savica V, Calò LA, Granata A, et al. A new approach to the evaluation of hyperphosphatemia in chronic kidney disease. Clin Nephrol. 2007;68:216-221.
7. Savica V, Calò LA, Caldarera R, et al. Phosphate salivary secretion in hemodialysis patients: Implications for the treatment of hyperphosphatemia. Nephron Physiol. 2007; 105:52-55.
8. Savica V, Calò LA, Monardo P, et al. Salivary phosphate-binding chewing gum reduces hyperphosphatemia in dialysis patients. J Am Soc Nephrol. 2009;20:639-644.
9. Calò LA, Savica V, Davis PA. Phosphorus in excess: A 'nutrient pollution' problem in the blood-broken hearts like broken lakes (eutrophication)? Eur J Clin Nutr. 2009;63:1460.
10. Davis PA, Savica V, Calò LA. PHOS-FAKE or PHOS-FATAL-Does intake of phosphate from foods lead to elevated plasma phosphate and its associated cardiovascular risks? Clin Nephrol. 2010;74:1-3.
11. Foley RN, Collins AJ, Herzog CA, Ishani A, Kalra PA. Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol. 2009;20:397-404.